Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Rieken, Stefan ^a   Gaiser, Timo ^a   Mohr, Angela ^a   Welzel, Thomas ^a   Witt, Olaf ^a   Kulozik, Andreas E ^a   Wick, Wolfgang ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; DACARBAZINE; HYDROXYUREA; LOMUSTINE; METHOTREXATE; METHYLPREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADULT; ALOPECIA; ARTICLE; BRAIN RADIOGRAPHY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; EVENT FREE SURVIVAL; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MALE; MEDULLOBLASTOMA; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTERIOR FOSSA; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SCHOOL CHILD; TREATMENT RESPONSE; VOMITING; ADOLESCENT; CANCER STAGING; CEREBELLUM TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; PATHOLOGY; RETROSPECTIVE STUDY; SKULL IRRADIATION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROSURGICAL PROCEDURES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955818659     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-450     Document Type: Article

References (39)

1. Russel DSRL. Pathology of tumors of the central nervous system. 1989, 5.
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114(2):97-109. 10.1007/s00401-007-0243-4, 1929165, 17618441.
3. Carrie C, Lasset C, Alapetite C, Haie-Meder C, Hoffstetter S, Demaille MC, Kerr C, Wagner JP, Lagrange JL, Maire JP, et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer 1994, 74(8):2352-2360. 10.1002/1097-0142(19941015)74:8<2352::AID-CNCR2820740821>3.0.CO;2-H, 7922986.
4. Haie-Meder C, Song PY. Medulloblastoma: differences in adults and children--regarding Frost et al., IJROBP 32:951-957; 1995 and Prados et al., IJROBP 32:1145-1152; 1995. Int J Radiat Oncol Biol Phys 1995, 32(4):1255-1257.
5. Ertas G, Ucer AR, Altundag MB, Durmus S, Calikoglu T, Ozbagi K, Abanuz H, Altundag K, Demirkasimoglu A. Medulloblastoma/primitive neuroectodermal tumor in adults: prognostic factors and treatment results: a single-center experience from Turkey. Med Oncol 2008, 25(1):69-72. 10.1007/s12032-007-0044-6, 18188718.
6. Paulino AC, Melian E. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Cancer 1999, 86(1):142-148. 10.1002/(SICI)1097-0142(19990701)86:1<142::AID-CNCR20>3.0.CO;2-Y, 10391574.
7. Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A. Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2002, 54(3):855-860.
8. Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990, 26(4):464-469.
9. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, et al. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 2005, 252(3):291-299. 10.1007/s00415-005-0560-2, 16189725.
10. Greenberg HS, Chamberlain MC, Glantz MJ, Wang S. Adult medulloblastoma: multiagent chemotherapy. Neuro Oncol 2001, 3(1):29-34. 10.1215/15228517-3-1-29, 1920599, 11305414.
11. Pramanik P, Sharma MC, Mukhopadhyay P, Singh VP, Sarkar C. A comparative study of classical vs. desmoplastic medulloblastomas. Neurol India 2003, 51(1):27-34.
12. Brandes AA, Ermani M, Amista P, Basso U, Vastola F, Gardiman M, Iuzzolino P, Turazzi S, Rotilio A, Volpin L, et al. The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys 2003, 57(3):755-761.
13. Chang CH, Housepian EM, Herbert C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969, 93(6):1351-1359.
14. Chatty EM, Earle KM. Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer 1971, 28(4):977-983. 10.1002/1097-0142(1971)28:4<977::AID-CNCR2820280422>3.0.CO;2-7, 5111749.
15. Sure U, Berghorn WJ, Bertalanffy H, Wakabayashi T, Yoshida J, Sugita K, Seeger W. Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 1995, 132(1-3):59-65. 10.1007/BF01404849, 7754860.
16. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005, 352(10):978-986. 10.1056/NEJMoa042176, 15758008.
17. Frost PJ, Laperriere NJ, Wong CS, Milosevic MF, Simpson WJ, Pintilie M. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995, 32(4):951-957.
18. Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 2009, 27(10):1627-1636. 10.1200/JCO.2008.17.9432, 19255330.
19. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000, 88(12):2887. 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F, 10870076.
20. Sterzing F, Schubert K, Sroka-Perez G, Kalz J, Debus J, Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008, 184(1):8-14. 10.1007/s00066-008-1778-6, 18188517.
21. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999, 17(3):832-845.
22. Zerbini C, Gelber RD, Weinberg D, Sallan SE, Barnes P, Kupsky W, Scott RM, Tarbell NJ. Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 1993, 11(4):616-622.
23. Douglas JG, Barker JL, Ellenbogen RG, Geyer JR. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. Int J Radiat Oncol Biol Phys 2004, 58(4):1161-1164.
24. Schofield D, West DC, Anthony DC, Marshal R, Sklar J. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol 1995, 146(2):472-480. 1869851, 7856756.
25. Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie-Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, et al. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 2007, 68(2):433-440.
26. Aragones MP, Magallon R, Piqueras C, Ley L, Vaquero J, Bravo G. Medulloblastoma in adulthood: prognostic factors influencing survival and recurrence. Acta Neurochir (Wien) 1994, 127(1-2):65-68. 10.1007/BF01808549, 7942185.
27. Hartsell WF, Montag AG, Lydon J, Galinsky DL, Sarin P. Treatment of medulloblastoma in adults. Am J Clin Oncol 1992, 15(3):207-211. 10.1097/00000421-199206000-00005, 1590272.
28. Sarkar C, Pramanik P, Karak AK, Mukhopadhyay P, Sharma MC, Singh VP, Mehta VS. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol 2002, 59(1):49-61. 10.1023/A:1016357731363, 12222838.
29. Giordana MT, Cavalla P, Dutto A, Borsotti L, Chio A, Schiffer D. Is medulloblastoma the same tumor in children and adults?. J Neurooncol 1997, 35(2):169-176. 10.1023/A:1005762727257, 9266455.
30. Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre ML, Grill J. Medulloblastoma in young children. Pediatr Blood Cancer 54(4):635-637. 10.1002/pbc.22372, 20146217.
31. Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990, 72(4):572-582. 10.3171/jns.1990.72.4.0572, 2319316.
32. Jenkin D, Goddard K, Armstrong D, Becker L, Berry M, Chan H, Doherty M, Greenberg M, Hendrick B, Hoffman H, et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990, 19(2):265-274.
33. Rieken S, Mohr A, Zipp L, Lindel K, Debus J, Combs SE. Behandlungsergebnisse und prognostische Faktoren nach Bestrahlung von Medulloblastomen. Onkologie 2010, 33(Suppl. 2):55-58.
34. Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, Chapman P, Loeffler JS. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 2000, 47(3):623-631. discussion 631-622, 10.1097/00006123-200009000-00018, 10981749.
35. Prados MD, Warnick RE, Wara WM, Larson DA, Lamborn K, Wilson CB. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995, 32(4):1145-1152.
36. Deutsch M, Thomas PR, Krischer J, Boyett JM, Albright L, Aronin P, Langston J, Allen JC, Packer RJ, Linggood R, et al. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg 1996, 24(4):167-176. discussion 176-167, 10.1159/000121042, 8873158.
37. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006, 24(25):4202-4208. 10.1200/JCO.2006.06.4980, 16943538.
38. Caglar K, Varan A, Akyuz C, Selek U, Kutluk T, Yalcin B, Atahan IL, Buyukpamukcu M. Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. J Pediatr Hematol Oncol 2006, 28(6):374-378. 10.1097/00043426-200606000-00010, 16794506.
39. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 1999, 17(7):2127-2136.